Using a data-based analysis to rank the best live albums from the 1970s. The list shows the decade could be the best-ever era ...

Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing ...

Why is Christian Science in our name? Our name is about honesty. The Monitor is owned by The Christian Science Church, and we’ve always been transparent about that. The Church publishes the ...

Using RIAA data, we ranked the best-selling artists of all time by the number of platinum albums they've sold in the US. While some the results are surprising - country singer Garth Brooks ...

THE WEEK'S TOP-SELLING ALBUMS ACROSS ALL GENRES, AS COMPILED BY LUMINATE. Jelly Roll New this week! Bailee & Buddy/Stoney Creek/BMG/Republic Highest ranking debut Gains In Performance Week of ...

Shifting a total of 87,000 copies on wax since its release in April, Tortured Poets stands tall as the best-selling album of the year so far overall. Upon its chart debut, Tay’s 11th Number 1 ...

Here are the top films of 1977, ranked by domestic box office. The film at No. 1 permanently changed what kinds of movies get made in Hollywood. Burt Reynolds was such a huge star in 1977 that he ...

Photos by Chanel Moye, Edwig Henson, Angel Ricciardi, David Muessig, Molly Matalon, & Kris Lori Fuentes Cortes ...

The Best Classical Music Albums of 2024 (So Far) Monday, October 7, 2024 All of these outstanding classical albums were Editor's Choices in Gramophone magazine and are highly recommended. If you are ...

That changed with the Dec. 5, 2009-dated chart, when catalog restrictions were lifted, turning the Billboard 200 into an all-inclusive list of the best-selling albums in the country, regardless of ...

The superstar’s selling prowess is on full display this week in a very special fashion. Swift claims half of all the spots inside the top 10 on the Top Album Sales chart, Billboard’s ranking ...

Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion by 2025, according to new research by GlobalData.